News Topical, Digital Desk : IPO Listing Today: Nephrocare Health's IPO was listed on the Indian stock market today. The company's initial public offering received a strong response from investors, and its shares were listed at a premium. The stock listed at Rs 491.70 on the BSE, a premium of 6.8 percent. Similarly, the stock listed at Rs 490 on the NSE, a premium of 6.52 percent (Nephrocare Health Share Price).
The Nephrocare Health Services IPO received a total subscription of 13.96 times
on the third and final day. According to NSE data, bids were received for 18.69 crore shares against the 1.34 crore shares for this issue of Rs 871 crore. This showed strong investor interest in the IPO. The IPO received a subscription of 27.47 times in the Qualified Institutional Buyers (QIB) segment. The issue was subscribed 24.27 times in the Non-Institutional Investors (NII) category. The IPO received a subscription of 2.31 times in the Retail Individual Investors (RII) segment.
Nephrocare Health Services Share Price The price band of the Nephrocare Health Services IPO was fixed at Rs 438 to Rs 460 per share. At the upper price band, the company's valuation is estimated at over Rs 4,600 crore. The IPO was open for investment from December 10 to December 12. The IPO included a fresh issue of ₹353.4 crore (approximately $1.53 billion). Additionally, an offer for sale of 11.2 million shares was placed, totaling ₹517.6 crore (approximately $1.77 billion). Consequently, the total IPO size was ₹871 crore (approximately $8.71 billion). The company has also clarified its plans for the use of the fresh issue proceeds. ₹129.1 crore (approximately $1.29 billion) will be used to expand its dialysis clinics in India. ₹136 crore (approximately $1.36 billion) will be used to repay debt. The remaining amount has been earmarked for general corporate purposes.
--Advertisement--
Share



